Private Label Nexium OTC Buoys Perrigo As Pricing Trims Rx Revenues
Executive Summary
Perrigo's third-quarter launch of private label Nexium24HR was primary contributor of $13m in new product sales in North America.
You may also be interested in...
Perrigo Generic Of Teva's ProAir Stunned By Another FDA CRL
Perrigo has got another Complete Response Letter on its generic version of Teva's ProAir, the company’s fourth to date, prompting a cut in its 2018 EPS guidance.
Perrigo Generic Of Teva's ProAir Stunned By Another FDA CRL
Perrigo has got another Complete Response Letter on its generic version of Teva's ProAir, the company’s fourth to date, prompting a cut in its 2018 EPS guidance.
Perrigo Finding Balance As Three-Legged Stool With Two Consumer Units, Rx Division
As new CEO Uwe Röhrhoff plans a "value creation" analysis, the improving Rx business growth could be essential for company because US competition from smaller, online brands is increasing in the OTC drug space and its sales of its consumer health products in Europe have yet to reach expectations.